E-LIB Suche - Ergebnisse für: Siebert, Nikolai

1

Long-term, continuous infusion of single-agent dinutuximab ..:

Lode, Holger N. ; Ehlert, Karoline ; Huber, Stephanie...
British Journal of Cancer. 129 (2023) 11 - p. 1780-1786 , 2023

Link: https://doi.org/10.1038/..

2

Combined Blockade of TIGIT and PD-L1 Enhances Anti-Neurobla..:

Siebert, Nikolai ; Zumpe, Maxi ; Schwencke, Christian Heinrich...
Cancers. 15 (2023) 13 - p. 3317 , 2023

Link: https://doi.org/10.3390/..

3

Effect and Tolerance of N5 and N6 Chemotherapy Cycles in Co..:

Lode, Holger N. ; Ladenstein, Ruth ; Troschke-Meurer, Sascha...
Cancers. 15 (2023) 13 - p. 3364 , 2023

Link: https://doi.org/10.3390/..

4

Chemotherapeutics Used for High-Risk Neuroblastoma Therapy ..:

Troschke-Meurer, Sascha ; Zumpe, Maxi ; Meißner, Lena...
Cancers. 15 (2023) 3 - p. 904 , 2023

Link: https://doi.org/10.3390/..

5

GMP-Compliant Manufacturing of TRUCKs: CAR T Cells targetin..:

Glienke, Wolfgang ; Dragon, Anna Christina ; Zimmermann, Katharina...
Frontiers in Immunology. 13 (2022) - p. , 2022

Link: https://doi.org/10.3389/..

6

Immunophenotyping of Circulating and Intratumoral Myeloid a..:

Marx, Sascha ; Wilken, Fabian ; Miebach, Lea...
Cancers. 14 (2022) 23 - p. 5751 , 2022

Link: https://doi.org/10.3390/..

7

BCL11B depletion induces the development of highly cytotoxi..:

Forkel, Hannes ; Grabarczyk, Piotr ; Depke, Maren...
OncoImmunology. 11 (2022) 1 - p. , 2022

Link: https://doi.org/10.1080/..

8

First-line Anti-GD2 Therapy Combined With Consolidation Che..:

Spasov, Neofit J. ; Dombrowski, Frank ; Lode, Holger N....
Journal of Pediatric Hematology/Oncology. 44 (2022) 6 - p. e948-e953 , 2022

Link: https://doi.org/10.1097/..

9

The Immunocytokine FAP-IL-2v Enhances Anti-Neuroblastoma Ef..:

Siebert, Nikolai ; Leopold, Justus ; Zumpe, Maxi...
Cancers. 14 (2022) 19 - p. 4842 , 2022

Link: https://doi.org/10.3390/..

10

Immune Response and Outcome of High-Risk Neuroblastoma Pati..:

Klingel, Leah ; Siebert, Nikolai ; Troschke-Meurer, Sascha...
Cancers. 14 (2022) 23 - p. 5802 , 2022

Link: https://doi.org/10.3390/..

11

Immunomonitoring of Stage IV Relapsed Neuroblastoma Patient..:

Seitz, Christian Martin ; Flaadt, Tim ; Mezger, Markus...
Frontiers in Immunology. 12 (2021) - p. , 2021

Link: https://doi.org/10.3389/..

12

Comparison of three different methods to detect bone marrow..:

Schriegel, Felix ; Taschner-Mandl, Sabine ; Bernkopf, Marie...
Journal of Cancer Research and Clinical Oncology. 148 (2021) 10 - p. 2581-2588 , 2021

Link: https://doi.org/10.1007/..

13

Reduction of CD11b+myeloid suppressive cells augments anti-..:

Siebert, Nikolai ; Zumpe, Maxi ; von Lojewski, Leon...
OncoImmunology. 9 (2020) 1 - p. , 2020

Link: https://doi.org/10.1080/..

14

GD2 targeting by dinutuximab beta is a promising immunother..:

Marx, Sascha ; Wilken, Fabian ; Wagner, Isabel...
Journal of Neuro-Oncology. 147 (2020) 3 - p. 577-585 , 2020

Link: https://doi.org/10.1007/..

15

Nivolumab and dinutuximab beta in two patients with refract..:

Ehlert, Karoline ; Hansjuergens, Ina ; Zinke, Andreas...
Journal for ImmunoTherapy of Cancer. 8 (2020) 1 - p. e000540 , 2020

Link: https://doi.org/10.1136/..